Search by Drug Name or NDC

    NDC 00078-0720-15 Jadenu 360 mg/1 Details

    Jadenu 360 mg/1

    Jadenu is a ORAL GRANULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is DEFERASIROX.

    Product Information

    NDC 00078-0720
    Product ID 0078-0720_d2bbabee-c3c6-4fda-8863-4418ad96d38e
    Associated GPIs 93100025003040
    GCN Sequence Number 077443
    GCN Sequence Number Description deferasirox GRAN PACK 360 MG ORAL
    HIC3 C8A
    HIC3 Description METALLIC POISON,AGENTS TO TREAT
    GCN 43466
    HICL Sequence Number 033337
    HICL Sequence Number Description DEFERASIROX
    Brand/Generic Brand
    Proprietary Name Jadenu
    Proprietary Name Suffix n/a
    Non-Proprietary Name deferasirox
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form GRANULE
    Route ORAL
    Active Ingredient Strength 360
    Active Ingredient Units mg/1
    Substance Name DEFERASIROX
    Labeler Name Novartis Pharmaceuticals Corporation
    Pharmaceutical Class Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA207968
    Listing Certified Through 2024-12-31

    Package

    NDC 00078-0720-15 (00078072015)

    NDC Package Code 0078-0720-15
    Billing NDC 00078072015
    Package 30 PACKET in 1 CARTON (0078-0720-15) / 1 GRANULE in 1 PACKET (0078-0720-19)
    Marketing Start Date 2017-05-18
    NDC Exclude Flag N
    Pricing Information N/A